Showing results (511-520 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|May 7, 2015
First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor TargetingRichard P Baum, Harshad R Kulkarni, Dirk Müller, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2021
LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH1Xiuqin Lu, Guohong Ge, Fang Ji, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2011
Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumorsDenis Rolando Beckford Vera, Sebastian Eigner, Milos Beran, et al.Cancer Biotherapy & Radiopharmaceuticals|May 24, 2014
On the application of Nafion membrane for the preparation of (90)Y skin patches, quality control, and biological evaluation for treatment of superficial tumorsSanjay Kumar Saxena, Usha Pandey, Yogendra Kumar, et al.Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapyS J DeNardo, P A Burke, B R Leigh, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibodyLeslie A Khawli, Mian M Alauddin, Peisheng Hu, et al.Cancer Biotherapy & Radiopharmaceuticals|March 19, 2026
Ultrasound-Responsive Folate-Chlorogenic Acid Nanocarrier Targeting Mixed Lineage Kinase 1 for Enhanced Wilms Tumor TherapyYanjiao Tang, Yunting Meng, Xiaomin Huang, et al.Cancer Biotherapy & Radiopharmaceuticals|May 7, 2026
Expanding the Therapeutic Window in Oncology: Modern Strategies and Future DirectionsShital Dange, Mohammed Musharraf Ali, Mamatha Gavisiddaiah, et al.Cancer Biotherapy & Radiopharmaceuticals|April 9, 2026
Ultrasound-Assisted Radiopharmaceutical Investigation of GNL1-Mediated AKT-P53-P21 Axis Activation in Cervical Cancer ProgressionYingying Jiang, Jing Ren, Junzhen TaoCancer Biotherapy & Radiopharmaceuticals|April 3, 2026
Prospective Clinical Assessment of Ultrasound-Assisted Radiopharmaceutical Imaging Under Anesthesia for Oncologic EvaluationQinghua Meng, Li Lin, Rongzhu LeiPageof 223